Concurrent psychiatric comorbidity and multimorbidity in a community study: gender differences and quality of life

  • Alex Gamma
  • Jules Angst
Quality Of Life


This study analysis of a community cohort at the age of 35 focused on the effects of gender and multimorbidity on quality of life and subjective distress. Consistent with an earlier analysis, quality of life decreased with increasing numbers of concurrent psychiatric diagnoses. Women generally reported lower quality of life and higher distress than men. Relative to men, well-being in women was subject to more diagnostic (alcohol abuse/dependence, depression, generalized anxiety disorder, bulimia) and social influences (partner, promotion). The same factors predicted women’s psychological and physical well-being, indicating a more holistic experience in women. Men’s physical well-being did not correlate with any of the diagnostic or social variables measured.

Key words

Quality of life distress prevalence gender comorbidity multimorbidity 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Angst J, Seilaro R, Merikangas KR (2001) Multimorbidity of psychiatric disorders as an indicator of clinical severity. Submitted to Eur Arch Psychiatry Clin NeurosciGoogle Scholar
  2. Bech P, Angst J (1996) Quality of life in anxiety and social phobia. Int Clin Psychopharmacol 11:97–100PubMedCrossRefGoogle Scholar
  3. Bech P, Staehr-Johansen K, Gudex C (1996) The WHO (Ten) Weil-Being Index: validation in diabetes. Psychother Psychosom 65: 138–190Google Scholar
  4. Bijl RV, Ravelli A, van Zerssen G (1998) Prevalence of psychiatric disorder in the general population: results of the Netherlands mental health survey and incidence study (NEMESIS). Soc Psychiatry Psychiatr Epidemiol 33: 587–595PubMedCrossRefGoogle Scholar
  5. Derogatis LR (1977) SCL-90. Administration, Scoring and Procedures Manual-I for the R (revised) version and other instruments of the Psychopathology Rating Scales Series. Johns Hopkins University School of Medicine, ChicagoGoogle Scholar
  6. Gijsen R, Hoeymans N, Schellevis FG, Ruwaard D, Satarino WA, van den Bos GA (2001) Causes and consequences of comorbidity: a review. J Clin Epidemiol 54:661–674PubMedCrossRefGoogle Scholar
  7. Kessler RC, Mcgonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen H-U, Kendler KS (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51: 8–19PubMedGoogle Scholar
  8. Ruggeri M, Warner R, Bisoffi G, Fontecedro L (2001) Subjective and objective dimensions of quality of life in psychiatric patients: a factor analytical approach. (The South Verona Outcome Project 4). Br J Psychiatry 178:268–275PubMedCrossRefGoogle Scholar
  9. Xuan J, Kirchdoerfer LJ, Boyer JG, Norwood GJ (1999) Effects of comorbidity on health-related quality-of-life scores: an analysis of clinical trial data. Clin Therapeutics 21:383–403CrossRefGoogle Scholar

Copyright information

© Steinkopff Verlag 2001

Authors and Affiliations

  1. 1.Zurich University Psychiatric HospitalZurichSwitzerland

Personalised recommendations